Cellebrite DI Ltd. (NASDAQ:CLBT) Given Average Recommendation of “Buy” by Brokerages

Cellebrite DI Ltd. (NASDAQ:CLBT) has been assigned an average rating of “Buy” from the eight ratings firms that are covering the stock, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $20.57.

A number of equities research analysts recently issued reports on CLBT shares. JPMorgan Chase & Co. upped their price target on shares of Cellebrite DI from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Monday, December 16th. Needham & Company LLC upped their target price on shares of Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. TD Cowen lifted their price target on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. Finally, Craig Hallum upped their price objective on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. grew its position in Cellebrite DI by 59.6% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock valued at $33,000 after acquiring an additional 1,017 shares in the last quarter. Tower View Wealth Management LLC boosted its position in Cellebrite DI by 1.2% in the 3rd quarter. Tower View Wealth Management LLC now owns 130,647 shares of the company’s stock valued at $2,200,000 after buying an additional 1,500 shares during the period. Quarry LP acquired a new position in shares of Cellebrite DI in the third quarter worth $27,000. Advisors Asset Management Inc. increased its position in shares of Cellebrite DI by 130.5% during the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock worth $52,000 after acquiring an additional 1,742 shares during the period. Finally, Venturi Wealth Management LLC raised its stake in shares of Cellebrite DI by 28.6% in the third quarter. Venturi Wealth Management LLC now owns 9,000 shares of the company’s stock valued at $152,000 after acquiring an additional 2,000 shares in the last quarter. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Cellebrite DI Trading Up 0.6 %

Shares of CLBT stock opened at $22.24 on Tuesday. Cellebrite DI has a 12 month low of $7.91 and a 12 month high of $22.91. The stock has a market cap of $4.58 billion, a P/E ratio of -14.35, a P/E/G ratio of 2.71 and a beta of 1.46. The company has a 50 day simple moving average of $20.04 and a two-hundred day simple moving average of $16.91.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The business had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. During the same period last year, the firm earned $0.09 earnings per share. The business’s quarterly revenue was up 27.0% on a year-over-year basis. As a group, equities analysts forecast that Cellebrite DI will post 0.32 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.